Korean J Helicobacter Up Gastrointest Res.  2011 Sep;11(2):103-111. 10.7704/kjhugr.2011.11.2.103.

Sequential Therapy of Helicobacter pylori Infection

Affiliations
  • 1Division of Gastroenterology, Department of Internal Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea College of Medicine, Incheon, Korea. gastro@catholic.ac.kr

Abstract

The standard therapy for Helicobacter pylori infection in Korea consists of a triple-drug regimen containing a proton pump inhibitor with two antibiotics such as clarithromycin, amoxicillin, and metronidazole. However, the eradication rate of this regimen is declining and a new regimen should be prompted. Among them, sequential therapy seems to be more effective than the conventional triple therapy. Sequential therapy, however, has only been tried in the limited countries such as Italy. To recommend this therapy in clinical practice, well-designed clinical trials should be performed in Korea since many host factors and bacterial factors influence the treatment outcomes. In this article, we are going to review the basic concepts and the results of previous clinical trials on sequential therapy.

Keyword

Helicobacter pylori; Therapy

MeSH Terms

Amoxicillin
Anti-Bacterial Agents
Clarithromycin
Helicobacter
Helicobacter pylori
Italy
Korea
Metronidazole
Proton Pumps
Amoxicillin
Anti-Bacterial Agents
Clarithromycin
Metronidazole
Proton Pumps
Full Text Links
  • KJHUGR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr